Core Insights - Keysight (KEYS) is expected to report quarterly earnings of $1.65 per share, reflecting a year-over-year increase of 17% [1] - Anticipated revenues for the quarter are projected to be $1.28 billion, indicating a 5% increase compared to the same quarter last year [1] Earnings Estimates Revisions - Over the past 30 days, the consensus EPS estimate has been adjusted downward by 0.3%, indicating a reassessment by analysts [2] - Revisions to earnings estimates are crucial for predicting investor actions and have shown a strong correlation with short-term stock price performance [3] Revenue Estimates by Segment - The consensus estimate for 'Revenue- Communications Solutions Group' is $884.15 million, reflecting a year-over-year change of +5.3% [5] - 'Revenue- Commercial Communications' is estimated at $588.52 million, suggesting a change of +4.5% year over year [5] - 'Revenue- Aerospace, Defense & Government' is forecasted to reach $295.62 million, indicating a change of +6.7% from the previous year [5] - 'Revenue- Electronic Industrial Solutions Group' is expected to be $395.34 million, with a year-over-year change of +5.1% [6] Income from Operations - 'Income from operations- Electronic Industrial Solutions Group' is projected to be $81.74 million, compared to $71 million from the previous year [6] - 'Income from operations- Communications Solutions Group' is expected to be $238.62 million, up from $223 million in the same quarter last year [7] Stock Performance - Keysight shares have increased by +22% in the past month, outperforming the +9% move of the Zacks S&P 500 composite [7] - The company holds a Zacks Rank 3 (Hold), suggesting it is expected to mirror overall market performance in the near future [7]

Core Viewpoint - Analysts forecast that Eagle Materials (EXP) will report quarterly earnings of $2.34 per share, reflecting a year-over-year increase of 4.5%, with revenues expected to reach $477.78 million, a slight increase of 0.2% compared to the previous year [1]. Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been adjusted downward by 3.3%, indicating a reassessment by analysts [2]. - Revisions to earnings estimates are crucial for predicting investor actions, as empirical research shows a strong correlation between earnings estimate trends and short-term stock performance [3]. Revenue Estimates - The consensus estimate for 'Revenue- Heavy Materials- Concrete & Aggregates' is $52.27 million, indicating a year-over-year change of +7.3% [5]. - 'Revenue- Gypsum Wallboard' is expected to be $207.84 million, suggesting a decline of -1.1% year over year [5]. - 'Revenue- Heavy Materials- Cement (Wholly Owned)' is projected to reach $185.88 million, reflecting a decrease of -1.9% from the previous year [5]. - Total Revenue for Heavy Materials is forecasted at $238.25 million, with a year-over-year change of +0.1% [6]. - 'Revenue- Light Materials- Gypsum Wallboard' is expected to be $198.60 million, indicating a decline of -5.5% year over year [6]. - Total Revenue for Light Materials is estimated at $238.70 million, suggesting no change year over year [7]. Pricing and Earnings Metrics - The Average Net Sales Price for Gypsum Wallboard is projected to be $240.74, compared to $232.62 from the previous year [7]. - The Average Net Sales Price for Cement is expected to reach $157.28, up from $154.59 in the same quarter last year [8]. - Segment Operating Earnings for Light Materials- Gypsum Wallboard is estimated at $81.51 million, down from $82.91 million year over year [9]. - Segment Operating Earnings for Light Materials is projected at $93.69 million, compared to $92.21 million from the previous year [9]. Stock Performance - Shares of Eagle Materials have increased by +8.3% over the past month, compared to a +9% increase in the Zacks S&P 500 composite [9]. - With a Zacks Rank 4 (Sell), Eagle Materials is expected to underperform the overall market in the near future [10].

Core Insights - Fox Corporation (FOXA) reported third-quarter fiscal 2025 adjusted earnings per share of $1.10, exceeding the Zacks Consensus Estimate by 18.28% and reflecting a year-over-year increase of 0.9% [1] - Revenues for the quarter rose 26.8% year over year to $4.37 billion, surpassing the consensus mark by 5.3% [1] - The company experienced significant growth in advertising revenues, which increased 64.9% year over year to $2.03 billion, driven by Super Bowl LIX and digital growth from the Tubi AVOD service [2] Revenue Breakdown - Affiliate fees, accounting for 45.9% of total revenues, grew 3.5% year over year to $2 billion, supported by 4% growth in the Television segment and 3% in the Cable Network Programming segment [1] - Cable Network Programming revenues increased 11.1% year over year to $1.63 billion, with advertising revenues growing 25.7% [4] - Television revenues rose 39.5% year over year to $2.70 billion, with advertising revenues jumping 77.2% [5] Operating Performance - Operating expenses increased 44.6% year over year to $2.96 billion, with expenses as a percentage of revenues expanding 840 basis points to 67.8% [6] - Selling, general & administrative (SG&A) expenses rose 8% year over year to $551 million, but as a percentage of revenues, they contracted 220 basis points to 12.6% [7] - Total adjusted EBITDA decreased 3.9% year over year to $856 million, with an adjusted EBITDA margin contracting 630 basis points to 19.6% [7] Financial Position - As of March 31, 2025, Fox had $4.81 billion in cash and cash equivalents, up from $3.32 billion as of December 31, 2024 [8] - The company's long-term debt stood at $600 million as of March 31, 2025 [8] Earnings Estimates - The Zacks Consensus Estimate for FOXA's 2025 earnings is currently $4.45 per share, indicating a year-over-year growth of 29.74% despite a 0.6% decline over the past 30 days [9] - The consensus estimate for FOXA's 2025 revenues is $15.88 billion, reflecting a year-over-year growth of 13.56% [10] Stock Performance - Following the strong third-quarter results, FOXA shares rose 6.33% in pre-market trading, with a year-to-date gain of 3.5% compared to the Zacks Consumer Discretionary sector's growth of 0.2% [3]

Shares of Amneal Pharmaceuticals (AMRX) have gained 7% over the past four weeks to close the last trading session at $7.46, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $11.50 indicates a potential upside of 54.2%.The mean estimate comprises four short-term price targets with a standard deviation of $0.58. While the lowest estimate of $11 indicates a 47.5% increase from the c ...

Core Insights - Analysts project that Steris (STE) will report quarterly earnings of $2.58 per share, reflecting a 7.1% year-over-year increase, with revenues expected to reach $1.48 billion, a 4.2% increase from the same quarter last year [1] Revenue Projections - 'Revenues- Healthcare' are projected to be $1.05 billion, indicating a 4.5% increase year-over-year [4] - 'Revenues- Healthcare Products- Service' are expected to reach $360.96 million, suggesting a 5.1% year-over-year increase [4] - 'Revenues- Healthcare Products- Capital equipment' is estimated at $327.37 million, reflecting a 1.3% decrease from the prior-year quarter [4] - 'Revenues- Healthcare Products- Consumables' are projected at $364.74 million, indicating a 9.6% year-over-year increase [5] - 'Revenues- Applied Sterilization Technologies (AST)' are expected to be $269.92 million, reflecting a 7.6% increase from the year-ago quarter [5] - 'Revenues- Life Sciences' are projected to reach $155.49 million, indicating a 3.2% decrease year-over-year [5] - 'Revenues- Life Sciences- Service' is expected to be $41.39 million, reflecting a 10% decrease year-over-year [6] - 'Revenues- Life Sciences- Consumables' are projected at $80.04 million, indicating a 13.7% year-over-year increase [6] - 'Revenues- Life Sciences- Capital equipment' is expected to be $35.43 million, reflecting a 19.9% decrease year-over-year [6] Operating Income Estimates - The consensus estimate for 'Operating income / (loss)- Healthcare' is $255.95 million, compared to $245.22 million reported in the same quarter last year [7] - 'Operating income / (loss)- Applied Sterilization Technologies (AST)' is estimated at $118.69 million, compared to $114.22 million reported in the same quarter last year [7] - The consensus for 'Operating income / (loss)- Life Sciences' is projected at $64.54 million, slightly up from $64.49 million reported in the previous year [8] Stock Performance - Steris shares have increased by 4% over the past month, while the Zacks S&P 500 composite has moved up by 13.7% [9] - With a Zacks Rank 2 (Buy), Steris is expected to outperform the overall market performance in the near term [10]

Core Viewpoint - Analysts project Cisco Systems (CSCO) will report quarterly earnings of $0.91 per share, reflecting a year-over-year increase of 3.4%, with revenues expected to reach $14.05 billion, a 10.6% increase from the same quarter last year [1]. Earnings Estimates - The consensus EPS estimate has been revised 0.4% higher in the last 30 days, indicating a collective reevaluation by analysts [2]. - Revisions to earnings estimates are crucial indicators for predicting investor actions regarding the stock, with empirical research showing a strong correlation between earnings estimate trends and short-term stock price performance [3]. Revenue Projections - The consensus estimate for 'Revenue- Product' is $10.06 billion, indicating an 11.5% increase year-over-year [5]. - 'Revenue- Services' is projected to reach $3.82 billion, reflecting a 3.8% year-over-year change [5]. - 'Revenue- Product- Security' is expected to be $2.19 billion, showing a significant increase of 68.3% from the prior-year quarter [5]. - 'Revenue- Product- Networking' is forecasted at $6.76 billion, with a year-over-year change of 3.6% [6]. - 'Revenue- Product- Collaboration' is estimated to reach $1.00 billion, indicating a 1.6% increase from the year-ago quarter [6]. Gross Margin Estimates - Analysts estimate 'Non-GAAP Gross Margin- Service' at $2.71 billion, up from $2.54 billion reported in the same quarter last year [7]. - 'Non-GAAP Gross Margin- Product' is projected to be $6.65 billion, compared to $6.04 billion reported in the same quarter of the previous year [7]. Stock Performance - Over the past month, Cisco shares have returned +5.5%, while the Zacks S&P 500 composite has changed +13.7% [7].

Core Viewpoint - Wall Street analysts predict that Global-e Online Ltd. (GLBE) will report a quarterly loss of $0.13 per share, reflecting a year-over-year increase of 31.6%, with revenues expected to reach $186.53 million, a 27.9% increase compared to the previous year [1]. Earnings Estimates - Over the last 30 days, there has been a significant downward revision of 58.3% in the consensus EPS estimate for the quarter, indicating a collective reassessment by analysts of their initial forecasts [2]. - Changes in earnings estimates are crucial for predicting potential investor reactions, as empirical studies show a strong correlation between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts estimate that 'Revenue by Category - Fulfillment services' will be $101.43 million, representing a year-over-year change of +30.7% [5]. - The forecast for 'Revenue by Category - Service fees' is $85.10 million, indicating a change of +24.7% from the year-ago quarter [5]. - The average prediction for 'Gross Merchandise Value' stands at $1.23 billion, compared to the year-ago value of $929.51 million [5]. Stock Performance - Over the past month, Global-e Online shares have recorded a return of +9.7%, while the Zacks S&P 500 composite has changed by +13.7% [6]. - Based on its Zacks Rank 3 (Hold), GLBE is expected to perform in line with the overall market in the upcoming period [6].

Core Viewpoint - Analysts forecast Dynatrace (DT) will report quarterly earnings of $0.30 per share, indicating no change from the previous year, with revenues expected to reach $434.56 million, reflecting a 14.1% increase year-over-year [1]. Earnings Estimates - Over the last 30 days, there has been a downward revision of 1.1% in the consensus EPS estimate for the quarter, indicating a collective reconsideration by analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical studies show a strong relationship between earnings estimate revisions and short-term stock price performance [3]. Revenue Projections - Analysts estimate 'Revenues- Services' at $21.78 million, representing a year-over-year change of +5% [5]. - 'Revenues- Subscriptions' are forecasted to reach $412.89 million, indicating a +14.7% change from the previous year [5]. - The 'Annual Recurring Revenue (ARR)- Total' is projected to be $1.71 billion, compared to $1.50 billion from the previous year [5]. Profit Estimates - The 'Gross profit- Services' is expected to be $3.05 million, down from $3.28 million reported in the same quarter last year [6]. - Analysts project 'Gross profit- Subscriptions' to be $361.62 million, an increase from $309.93 million reported in the same quarter of the previous year [6]. Stock Performance - Shares of Dynatrace have increased by +11.9% over the past month, compared to a +13.7% increase in the Zacks S&P 500 composite [7]. - With a Zacks Rank 3 (Hold), Dynatrace is expected to perform in line with the overall market in the near future [7].

Core Viewpoint - The market anticipates Birkenstock (BIRK) to report a year-over-year increase in earnings driven by higher revenues for the quarter ending March 2025, with actual results being crucial for stock price movement [1][2]. Earnings Expectations - The consensus EPS estimate for Birkenstock is $0.57 per share, reflecting a year-over-year increase of +29.6% [3]. - Expected revenues are projected at $610.3 million, which is a 16.8% increase from the same quarter last year [3]. Estimate Revisions - Over the last 30 days, the consensus EPS estimate has been revised 0.86% higher, indicating a positive reassessment by analysts [4]. - The Most Accurate Estimate for Birkenstock is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +2.20% [10][11]. Earnings Surprise Prediction - A positive Earnings ESP is a strong indicator of a potential earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [8]. - Birkenstock currently holds a Zacks Rank of 2, suggesting a high likelihood of beating the consensus EPS estimate [11]. Historical Performance - In the last reported quarter, Birkenstock exceeded the expected earnings of $0.16 per share by delivering $0.19, resulting in a surprise of +18.75% [12]. - Over the past four quarters, the company has beaten consensus EPS estimates three times [13]. Conclusion - Birkenstock is positioned as a compelling candidate for an earnings beat, but investors should consider other influencing factors before making investment decisions [16].

Group 1 - Pfizer (PFE) closed at $22.79, with a 1.3% gain over the past four weeks, and a mean price target of $28.52 indicating a 25.1% upside potential [1] - The average of 21 short-term price targets ranges from $23 to $35, with a standard deviation of $3.16, suggesting variability in analyst estimates [2] - Analysts have shown increasing optimism about PFE's earnings prospects, with a 3.2% increase in the Zacks Consensus Estimate for the current year and no negative revisions [12][11] Group 2 - The Zacks Rank for PFE is 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - A tight clustering of price targets, indicated by a low standard deviation, suggests a high degree of agreement among analysts regarding the stock's price movement [9] - While price targets can be misleading, the direction implied by them may serve as a useful guide for further research into the stock's potential [10][7]